Bioceres Crop Solutions Corp (BIOX)

NASDAQ


Symbol		Exchange		Currency
BIOX	·	NASDAQ	·	USD	Real-time
BIOXm	·	Buenos Aires	·	ARS	Delayed

Currency in USD

BIOX Pro Research

0.2100

-0.0120(-5.41%)

Closed·13/11

After Hours

0.2041-0.0059(-2.81%)

·13/11

Fair Value

Unlock Value

Day's Range

0.2075

0.2278

52 wk Range

0.1900

1.7320

BIOX Income Statement

Assess the Bioceres Crop income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the BIOX net worth.

Period Ending:

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

328.46

419.45

420.44

287.66

237.84

Total Revenues Growth

aa.aa

+58.91%

+27.7%

+0.24%

-31.58%

-17.32%

Cost Of Revenues

aa.aa

203.56

241.46

267.66

186.07

156.6

Gross Profit

aa.aa

124.9

177.99

152.78

101.59

81.23

Gross Profit Growth

aa.aa

+41.36%

+42.51%

-14.16%

-33.51%

-20.04%

Gross Profit Margin %

aa.aa

38.03%

42.43%

36.34%

35.32%

34.16%

Other Operating Expenses, Total

aa.aa

86.17

125

105.73

101.62

89.27

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+69.24%	+45.06%	-15.42%	-3.89%	-12.15%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	6.86	14.89	8.22	9.36	11
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	65.31	99.4	80.72	79.57	61.27
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14	10.7	16.79	12.69	17.01

Operating Income

aa.aa

38.73

52.99

47.05

-0.03

-8.04

Operating Income Growth

aa.aa

+3.44%

+36.82%

-11.2%

-100.06%

-29,350.77%

EBIT Margin %

aa.aa

11.79%

12.63%

11.19%

-0.01%

-3.38%

Net Interest Expenses

aa.aa

-14.95

-21.23

-22.07

-21.89

-35.4

Net Interest Expenses Growth

aa.aa

+20.98%

-41.98%

-3.98%

+0.85%

-61.74%

Interest Expense, Total

aa.aa

-14.95

-21.23

-22.07

-21.89

-35.4

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-9.71

-12.65

-3.75

-32.35

-16.46

EBT, Excl. Unusual Items

aa.aa

14.06

19.11

21.22

-54.27

-59.9

Gain (Loss) On Sale Of Assets

aa.aa

7.75

-15.58

Other Unusual Items, Total

aa.aa

1.03

EBT, Incl. Unusual Items

aa.aa

14.06

19.11

22.26

-46.52

-75.48

EBT, Incl. Unusual Items Growth

aa.aa

+33.55%

+35.85%

+16.49%

-309.01%

-62.26%

EBT, Incl. Unusual Items Margin

aa.aa

4.28%

4.56%

5.29%

-16.17%

-31.74%

Income Tax Expense

aa.aa

17.97

-1.07

6.6

2.62

6.96

Net Income to Company

aa.aa

-3.91

20.17

7.29

-58.85

-263.94

Minority Interest

aa.aa

-3.29

-1.39

-3.01

3.43

5.79

Net Income

aa.aa

-7.2

18.78

4.28

-55.42

-258.15

Net Income Growth

aa.aa

-4.8%

+360.85%

-77.23%

-1,396.07%

-365.84%

Net Income Margin %

aa.aa

-2.19%

4.48%

1.02%

-19.26%

-108.54%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-7.2

18.78

12.64

-45.71

-76.65

Basic EPS - Continuing Operations

aa.aa

-0.17

0.3

0.2

-0.72

-1.2

Basic EPS - Continuing Operations Growth

aa.aa

+2.84%

+277.56%

-33.44%

-459.42%

-66.59%

Diluted EPS - Continuing Operations

aa.aa

-0.17

0.3

0.2

-0.72

-1.2

Diluted EPS - Continuing Operations Growth

aa.aa

+2.85%

+274.62%

-33.01%

-463.08%

-66.59%

Basic Weighted Average Shares Outstanding

aa.aa

42.3

62.15

62.84

63.23

63.65

Diluted Weighted Average Shares Outstanding

aa.aa

42.3

63.19

63.49

63.23

63.65

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

46.66

68.81

56.51

10.13

3.3

EBITDA Growth

aa.aa

+9.83%

+47.48%

-17.87%

-82.07%

-67.44%

EBITDA Margin %

aa.aa

14.2%

16.4%

13.44%

3.52%

1.39%

EBIT

aa.aa

38.73

52.99

47.05

-0.03

-8.04

* In Millions of USD (except for per share items)

FAQ

What was Bioceres Crop’s revenue at year end?

At the end of the last reported fiscal year, Bioceres Crop (BIOX) recorded total revenue of 237.8353 million USD.

How much revenue did Bioceres Crop report in the most recent quarter?

In its most recent quarterly earnings report, Bioceres Crop posted revenue of 53.9000 million USD.

What was Bioceres Crop’s net income for the year?

For the full year, Bioceres Crop reported net income of -258.1514 million USD.

How much net income did Bioceres Crop post in the last quarter?

In the most recent quarter, Bioceres Crop (BIOX) posted net income of -9.9000 million USD.

What was Bioceres Crop’s gross profit for the year?

Gross profit for the year was reported at 81.2332 million USD.

How much gross profit did Bioceres Crop generate last quarter?

Bioceres Crop recorded gross profit of 19.1000 million USD in its latest quarterly report.

What was Bioceres Crop’s annual operating income?

For the full year, Bioceres Crop (BIOX) reported operating income of -8.0409 million USD.

What was Bioceres Crop’s operating income last quarter?

Quarterly operating income was -0.2000 million USD.

What was Bioceres Crop’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2.6350 million USD.

What was the quarter-over-quarter change in EBITDA for Bioceres Crop?

EBITDA changed by 152.8812% million USD compared to the last quarter.

What is Bioceres Crop’s most recent gross profit margin?

The latest reported gross profit margin for Bioceres Crop (BIOX) is 35.4359% million USD.

What is Bioceres Crop’s most recent net income margin?

Net income margin based on recent financials is -18.3673% million USD.

What is Bioceres Crop’s most recent EBIT margin?

Bioceres Crop reported an EBIT margin of -0.3710% million USD based on current figures.

How did Bioceres Crop’s revenue change compared to the previous quarter?

Revenue changed by -5.4386% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Bioceres Crop?

In the latest quarter, gross profit changed by 49.2188% million USD from the previous quarter.

S&P/TSX

36,105.90

-31.29

-0.09%

S&P/TSX 60

2,152.11

-2.49

-0.12%

US 30

52,263.30

-35.8

-0.07%

US 500

7,541.00

-51.9

-0.68%

S&P 500 VIX

19.30

+0.60

+3.21%

DAX

26,749.95

-21.93

-0.08%

Dollar Index

103.33

+0.240

+0.23%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	70.91	+1.24%	16.17M
Enbridge	67.96	-0.89%	12.57M
RBC	288.37	-0.35%	2.72M
Bank of Montreal	247.02	+0.13%	2.56M
Suncor Energy	99.66	+0.87%	5.87M
TD	176.42	-0.15%	2.58M
Canadian Imperial Bank	164.99	-0.33%	2.57M

Name	Last	Chg. %	Vol.
Mijem Newcomm Tech	0.10	+375.00%	27.00K
Plaid	0.14	+133.33%	2.00K
Fuse Battery	0.0350	+133.33%	306.22K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Playground Ventures	0.010	+100.00%	8.00K
ePlay Digital	0.010	+100.00%	7.00K
Nuinsco Resources	0.0100	+100.00%	15.00K

Name	Last	Chg. %	Vol.
nDatalyze	0.01	-66.67%	81.00K
Abound Energy	0.10	-62.96%	5.00K
Colossus Resources	0.03	-60.00%	40.00K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K
James Bay Resources Ltd	0.005	-50.00%	35.10K
Zonetail	0.02	-50.00%	82.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	342.32	-5.42%	574.71K
NVIDIA DRC	36.14	-1.95%	534.27K
Canopy Growth	0.810	-1.22%	795.27K
Telus	12.14	0.00%	5.20M
Intel Corp DRC	33.38	-2.57%	45.91K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa Aa	35.51	+52.59%	54.19
Aaa Aaaaaaaaaaaa Aa	18.13	+49.03%	27.02
Aaaaaaa	10.23	+48.62%	15.20
Aaaaaa A Aaa	24.71	+48.59%	36.72
Aaaaa A	9.38	+48.31%	13.91
Aa Aaa Aaaa	106.48	+46.28%	155.76
Aaaaaaaaa	31.24	+46.07%	45.63

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaa Aa	35.51	+52.59%	54.19
Aaa Aaaaaaaaaaaa Aa	18.13	+49.03%	27.02
Aaaaaaa	10.23	+48.62%	15.20
Aaaaaa A Aaa	24.71	+48.59%	36.72
Aaaaa A	9.38	+48.31%	13.91
Aa Aaa Aaaa	106.48	+46.28%	155.76
Aaaaaaaaa	31.24	+46.07%	45.63

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.